Sepragel Ent Bioresorbable Packing/Stent
Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material). 510(k) K043035, from Genzyme Corporation (Cambridge, MA). Product code KHJ, class 2.
As of Nov 20, 2026, K043035 is an FDA 510(k) held by Genzyme Corporation, substantially equivalent on Jul 11, 2005 after 250 days, with no recalls tied to it in FDA's recall database.
- Review time: 250 days
- Recalls: 0
- Cited as a predicate by: 3 devices
Sepragel ENT packing/stent is indicated for use in patients undergoing nasal/sinus, middle ear and external ear canal surgery as a space-occupying dressing and/or stent intended to prevent adhesions in the nasal cavity, separate mucosal surfaces, help control minimal bleeding following surgery or trauma, and act as an adjunct to aid in the natural healing process.
- Sepragel SinusK012532 · Genzyme Corp. · Oct 30, 2001
- HylasineK993362 · Biomatrix, Inc. · Mar 13, 2000
- Merogel Otologic PackK001148 · Xomed, Inc. · Jun 3, 2000
- Merogel Control Gel Ent Surgical DressingK002972 · Medtronic Xomed · Dec 15, 2000
- Nasal/Epistaxis PackK113585 · Cogent Therapeutics, LLC · Apr 25, 2012
- Merogel Injectable Bioresorbable StentK070886 · Medtronic, Inc. · Apr 26, 2007
- Ostene, Aoc, Osteotene, Ceretene, Cerepor, Aptene, Apatene and ActipasteK062280 · Ceremed , Inc. · Dec 11, 2006
- Tympendi™ (810)K260266 · Grace Medical, Inc. · Aug 18, 2026
- Biodesign Otologic Butterfly Graft (ENT-OTO-BFLY-0.4-0.6); Biodesign Otologic Butterfly Graft (ENT-OTO-BFLY-0.6-0.9)K232646 · Cook Biotech Incorporated · May 24, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 3, 2004
- Review panel
- Ear, Nose, Throat
- Regulation
- 21 CFR 874.3620
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files